GlassScriptPhysician profile
Jason W Harper
NPI 1336305911
$14,563.62
in general payments reported to CMS, 2019-2025
7 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2021: $420 · 2022: $203 · 2023: $3,600 · 2024: $9,861 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $1,227 · Food and Beverage: $902 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,598.75 |
| Travel and Lodging | $1,226.56 |
| Food and Beverage | $901.58 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $10,954.72 | 2023-2025 | Tremfya, Stelara |
| E.R. Squibb & Sons, L.L.C. | $2,206.94 | 2023-2025 | Camzyos |
| Abbvie INC. | $821.33 | 2021-2024 | |
| Janssen Biotech, INC. | $327.62 | 2021-2025 | Tremfya, Stelara |
| Celgene Corporation | $128.71 | 2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $124.30 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.